Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo.
Buerkle
Martin A
MA
Institute of Physiology, Medizinische Poliklinik-Innenstadt, Ludwig-Maximilians University, Munich, Germany.
Lehrer
Selim
S
Sohn
Hae-Young
HY
Conzen
Peter
P
Pohl
Ulrich
U
Krötz
Florian
F
D015121:6-Ketoprostaglandin F1 alpha / Q000378:metabolism; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000818:Animals; D001160:Arterioles / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology; D001241:Aspirin / Q000494:pharmacology; D002478:Cells, Cultured / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D006224:Cricetinae; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology* / Q000633:toxicity; D042783:Endothelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D004730:Endothelium, Vascular / Q000166:cytology; D006801:Humans; D016285:Iloprost / Q000494:pharmacology; D008565:Membrane Proteins; D008647:Mesocricetus; D009578:Nitrobenzenes / Q000494:pharmacology; D015539:Platelet Activation / Q000187:drug effects; D010973:Platelet Adhesiveness / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology*; D012884:Skin Window Technique; D013449:Sulfonamides / Q000494:pharmacology; D019851:Thrombophilia / Q000139:chemically induced; D014471:Umbilical Veins
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D008565:Membrane Proteins; D009578:Nitrobenzenes; D010975:Platelet Aggregation Inhibitors; D013449:Sulfonamides; C080955:N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide; D015121:6-Ketoprostaglandin F1 alpha; D000244:Adenosine Diphosphate; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D016285:Iloprost; D001241:Aspirin